{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidaxgt42vgog745ap34ix3hndy7o43ebtd7mez6puzw7gtjgs7ssu",
    "uri": "at://did:plc:bbnssswytihj7d2gpoyixijw/app.bsky.feed.post/3mfne3t5j7kp2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreia4226lmx6krsrb5qpmpxud5qvetfsn6ty7xxmwztdsxevoncnx7i"
    },
    "mimeType": "image/jpeg",
    "size": 41926
  },
  "path": "/article/2516913-landmark-vitiligo-cream-targets-immune-cells-that-disrupt-pigmentation/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home",
  "publishedAt": "2026-02-24T13:52:44.000Z",
  "site": "https://www.newscientist.com",
  "textContent": "A cream that directly disrupts the underlying causes of the skin patches seen in the condition vitiligo will be made available on the NHS",
  "title": "Landmark vitiligo cream targets immune cells that disrupt pigmentation"
}